{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:57:50Z","timestamp":1773219470800,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R359-2020-2620"],"award-info":[{"award-number":["R359-2020-2620"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001708","name":"International Foundation for Research in Paraplegia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41393-026-01172-7","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:30:52Z","timestamp":1770291052000},"page":"288-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal trends in gabapentinoid use for the acute management of spinal cord injury: a retrospective cohort study"],"prefix":"10.1038","volume":"64","author":[{"given":"Bobo","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0415-5284","authenticated-orcid":false,"given":"Jaycee R.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3226-9218","authenticated-orcid":false,"given":"Vanessa K.","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6284-938X","authenticated-orcid":false,"given":"Jacquelyn J.","family":"Cragg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Griesdale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"Shuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7722-131X","authenticated-orcid":false,"given":"John LK","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"1172_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpain.2021.06.013","volume":"23","author":"J Rosner","year":"2022","unstructured":"Rosner J, Negraeff M, B\u00e9langer LM, Tsang A, Ritchie L, Mac-Thiong JM, et al. Characterization of hyperacute neuropathic pain after spinal cord injury: a prospective study. The journal of pain : official journal of the American Pain Society. 2022;23:89\u201397. https:\/\/doi.org\/10.1016\/j.jpain.2021.06.013","journal-title":"The journal of pain : official journal of the American Pain Society"},{"key":"1172_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.apmr.2021.06.022","volume":"103","author":"ER Felix","year":"2022","unstructured":"Felix ER, Cardenas DD, Bryce TN, Charlifue S, Lee TK, MacIntyre B, et al. Prevalence and impact of neuropathic and nonneuropathic pain in chronic spinal cord injury. Arch Phys Med Rehabil. 2022;103:729\u201337. https:\/\/doi.org\/10.1016\/j.apmr.2021.06.022","journal-title":"Arch Phys Med Rehabil"},{"key":"1172_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/EJP.905","volume":"21","author":"D Burke","year":"2017","unstructured":"Burke D, Fullen BM, Stokes D, Lennon O. Neuropathic pain prevalence following spinal cord injury: A systematic review and meta-analysis. Eur J Pain. 2017;21:29\u201344. https:\/\/doi.org\/10.1002\/EJP.905","journal-title":"Eur J Pain"},{"key":"1172_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/RAPM-2020-101960","volume":"46","author":"C Hunt","year":"2021","unstructured":"Hunt C, Moman R, Peterson A, Wilson R, Covington S, Mustafa R, et al. Prevalence of chronic pain after spinal cord injury: a systematic review and meta-analysis. Reg Anesth Pain Med. 2021;46:328\u201336. https:\/\/doi.org\/10.1136\/RAPM-2020-101960","journal-title":"Reg Anesth Pain Med"},{"key":"1172_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jpain.2013.09.008","volume":"15","author":"NB Finnerup","year":"2014","unstructured":"Finnerup NB, Norrbrink C, Trok K, Piehl F, Johannesen IL, S\u00f8rensen JC, et al. Phenotypes and predictors of pain following traumatic spinal cord injury: A prospective study. The journal of pain : official journal of the American Pain Society. 2014;15:40\u20138. https:\/\/doi.org\/10.1016\/j.jpain.2013.09.008","journal-title":"The journal of pain : official journal of the American Pain Society"},{"key":"1172_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.apmr.2022.07.005","volume":"104","author":"TC Crul","year":"2023","unstructured":"Crul TC, Post MWM, Visser-Meily JMA, Stolwijk-Sw\u00fcste JM. Prevalence and determinants of pain in spinal cord injury during initial inpatient rehabilitation: data from the dutch spinal cord injury database. Arch Phys Med Rehabil. 2023;104:74\u201382. https:\/\/doi.org\/10.1016\/j.apmr.2022.07.005","journal-title":"Arch Phys Med Rehabil"},{"key":"1172_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.46292\/SCI2603-133","volume":"26","author":"J Varghese","year":"2020","unstructured":"Varghese J, Anderson KD, Widerstr\u00f6m-Noga E, Mehan U. A primary care provider\u2019s guide to pain after spinal cord injury: screening and management. Top Spinal Cord Inj Rehabil. 2020;26:133 https:\/\/doi.org\/10.46292\/SCI2603-133","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"1172_CR8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/S40265-023-01903-7","volume":"83","author":"E Widerstr\u00f6m-Noga","year":"2023","unstructured":"Widerstr\u00f6m-Noga E. Neuropathic pain and spinal cord injury: management, phenotypes, and biomarkers. Drugs. 2023;83:1001\u201325. https:\/\/doi.org\/10.1007\/S40265-023-01903-7","journal-title":"Drugs"},{"key":"1172_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/10790268.2024.2309421","volume":"48","author":"K Saita","year":"2024","unstructured":"Saita K, Sumitani M, Koyama Y, Sugita S, Matsubayashi Y, Ogata T, et al. Neuropathic pain development and maintenance and its association with motor recovery after cervical spinal cord injury. J Spinal Cord Med. 2024;48:585\u201392. https:\/\/doi.org\/10.1080\/10790268.2024.2309421","journal-title":"J Spinal Cord Med"},{"key":"1172_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12272-013-0057-y","volume":"36","author":"A Kukkar","year":"2013","unstructured":"Kukkar A, Bali A, Singh N, Jaggi AS. Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res. 2013;36:237\u201351. https:\/\/doi.org\/10.1007\/s12272-013-0057-y","journal-title":"Arch Pharm Res"},{"key":"1172_CR11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/J.BJA.2018.02.066","volume":"120","author":"M Chincholkar","year":"2018","unstructured":"Chincholkar M. Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review. Br J Anaesth. 2018;120:1315\u201334. https:\/\/doi.org\/10.1016\/J.BJA.2018.02.066","journal-title":"Br J Anaesth"},{"key":"1172_CR12","doi-asserted-by":"publisher","first-page":"CD007076","DOI":"10.1002\/14651858.CD007076.PUB3","volume":"1","author":"S Derry","year":"2019","unstructured":"Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019;1:CD007076 https:\/\/doi.org\/10.1002\/14651858.CD007076.PUB3","journal-title":"Cochrane Database Syst Rev"},{"key":"1172_CR13","doi-asserted-by":"publisher","first-page":"CD007938","DOI":"10.1002\/14651858.CD007938.PUB4","volume":"6","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Derry S, Bell RF, Rice ASC, T\u00f6lle TR, Phillips T, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6:CD007938 https:\/\/doi.org\/10.1002\/14651858.CD007938.PUB4","journal-title":"Cochrane Database Syst Rev"},{"key":"1172_CR14","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41380-021-01386-6","volume":"27","author":"JSW Hong","year":"2021","unstructured":"Hong JSW, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, et al. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Mol Psychiatry. 2021;27:1339\u201349. https:\/\/doi.org\/10.1038\/s41380-021-01386-6","journal-title":"Mol Psychiatry"},{"key":"1172_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.mayocpiqo.2022.12.002","volume":"7","author":"LL Huang","year":"2023","unstructured":"Huang LL, Wright JA, Fischer KM, Croghan IT, Nanda S, Schroeder DR, et al. Gabapentinoid prescribing practices at a large academic medical center. Mayo Clin. Proc. Innov. Qual. Outcomes. 2023;7:58\u201368. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2022.12.002","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"1172_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.18553\/JMCP.2003.9.6.559","volume":"9","author":"A Mack","year":"2015","unstructured":"Mack A. Examination of the evidence for off-label use of gabapentin. Journal of managed care pharmacy : JMCP. 2015;9:559\u201368. https:\/\/doi.org\/10.18553\/JMCP.2003.9.6.559","journal-title":"Journal of managed care pharmacy : JMCP"},{"key":"1172_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-40637-8","volume":"14","author":"AYL Chan","year":"2023","unstructured":"Chan AYL, Yuen ASC, Tsai DHT, Lau WCY, Jani YH, Hsia Y, et al. Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study. Nat Commun. 2023;14:1\u201311.","journal-title":"Nat Commun"},{"key":"1172_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10754-021-09307-4","volume":"22","author":"W Encinosa","year":"2022","unstructured":"Encinosa W, Bernard D, Selden TM. Opioid and non-opioid analgesic prescribing before and after the CDC\u2019s 2016 opioid guideline. Int. J. Health Econ. Manag. 2022;22:1\u201352. https:\/\/doi.org\/10.1007\/s10754-021-09307-4","journal-title":"Int. J. Health Econ. Manag."},{"key":"1172_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/AJP.0000000000000523","volume":"34","author":"LMA B\u00e9langer","year":"2018","unstructured":"B\u00e9langer LMA, Umedaly HS, Noonan VK, Park SE, Prince J, Thorogood NP, et al. Evaluation of a clinical protocol to assess and diagnose neuropathic pain during acute hospital admission results from traumatic spinal cord injury. Clin J Pain. 2018;34:104\u201312. https:\/\/doi.org\/10.1097\/AJP.0000000000000523","journal-title":"Clin J Pain"},{"key":"1172_CR20","doi-asserted-by":"publisher","first-page":"E3412","DOI":"10.1212\/WNL.0000000000010950","volume":"95","author":"FM Warner","year":"2020","unstructured":"Warner FM, Cragg JJ, Jutzeler CR, Grassner L, MacH O, Maier DD, et al. Association of timing of gabapentinoid use with motor recovery after spinal cord injury. Neurology. 2020;95:E3412\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000010950","journal-title":"Neurology"},{"key":"1172_CR21","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1177\/1545968320931516","volume":"34","author":"JJ Cragg","year":"2020","unstructured":"Cragg JJ, Jutzeler CR, Grassner L, Ramer M, Bradke F, Kramer JLK. Beneficial \u201cpharmaceutical pleiotropy\u201d of gabapentinoids in spinal cord injury: a case for refining standard-of-care. Neurorehabil Neural Repair. 2020;34:686\u20139. https:\/\/doi.org\/10.1177\/1545968320931516","journal-title":"Neurorehabil Neural Repair"},{"key":"1172_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/J.NEURON.2016.09.026\/ATTACHMENT\/D5BB7F7E-B452-419A-ADAD-6393BC2C4AFF\/MMC4.PDF","volume":"92","author":"A Tedeschi","year":"2016","unstructured":"Tedeschi A, Dupraz S, Laskowski CJ, Xue J, Ulas T, Beyer M, et al. The calcium channel subunit Alpha2delta2 suppresses axon regeneration in the adult CNS. Neuron. 2016;92:419\u201334. https:\/\/doi.org\/10.1016\/J.NEURON.2016.09.026\/ATTACHMENT\/D5BB7F7E-B452-419A-ADAD-6393BC2C4AFF\/MMC4.PDF","journal-title":"Neuron"},{"key":"1172_CR23","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/J.CELREP.2017.01.048","volume":"18","author":"FM Warner","year":"2017","unstructured":"Warner FM, Cragg JJ, Jutzeler CR, R\u00f6hrich F, Weidner N, Saur M, et al. Early administration of gabapentinoids improves motor recovery after human spinal cord injury. Cell Rep. 2017;18:1614\u20138. https:\/\/doi.org\/10.1016\/J.CELREP.2017.01.048","journal-title":"Cell Rep."},{"key":"1172_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1172\/JCI130391","volume":"130","author":"W Sun","year":"2020","unstructured":"Sun W, Larson MJE, Kiyoshi CM, Annett AJ, Stalker WA, Peng J, et al. Gabapentinoid treatment promotes corticospinal plasticity and regeneration following murine spinal cord injury. J Clin Invest. 2020;130:345\u201358. https:\/\/doi.org\/10.1172\/JCI130391","journal-title":"J Clin Invest"},{"key":"1172_CR25","doi-asserted-by":"publisher","first-page":"1033386","DOI":"10.3389\/fneur.2022.1033386","volume":"13","author":"JR Wilson","year":"2022","unstructured":"Wilson JR, Doty S, Petitt JC, El-Abtah M, Francis JJ, Sharpe MG, et al. Feasibility of gabapentin as an intervention for neurorecovery after an acute spinal cord injury: Protocol. Front Neurol. 2022;13:1033386. 10.3389\/FNEUR.2022.1033386.","journal-title":"Front Neurol"},{"key":"1172_CR26","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/J.APMR.2014.06.010","volume":"95","author":"S Mehta","year":"2014","unstructured":"Mehta S, McIntyre A, Dijkers M, Loh E, Teasell RW. Gabapentinoids are effective in decreasing neuropathic pain and other secondary outcomes after spinal cord injury: a meta-analysis. Arch Phys Med Rehabil. 2014;95:2180\u20136. https:\/\/doi.org\/10.1016\/J.APMR.2014.06.010","journal-title":"Arch Phys Med Rehabil"},{"key":"1172_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/SC.2011.109","volume":"50","author":"VK Noonan","year":"2012","unstructured":"Noonan VK, Kwon BK, Soril L, Fehlings MG, Hurlbert RJ, Townson A, et al. The rick hansen spinal cord injury registry (RHSCIR): a national patient-registry. Spinal Cord. 2012;50:22\u20137. https:\/\/doi.org\/10.1038\/SC.2011.109","journal-title":"Spinal Cord"},{"key":"1172_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.46292\/SCI2702-1","volume":"27","author":"R Rupp","year":"2021","unstructured":"Rupp R, Biering-S\u00f8rensen F, Burns SP, Graves DE, Guest J, Jones L, et al. International standards for neurological classification of spinal cord injuryrevised 2019. Top Spinal Cord Inj Rehabil. 2021;27:1\u201322. https:\/\/doi.org\/10.46292\/SCI2702-1","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"1172_CR29","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"1172_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3171\/2018.10.SPINE18802","volume":"30","author":"MH Khorasanizadeh","year":"2019","unstructured":"Khorasanizadeh MH, Yousefifard M, Eskian M, Lu Y, Chalangari M, Harrop JS, et al. Neurological recovery following traumatic spinal cord injury: a systematic review and meta-analysis. J Neurosurg Spine. 2019;30:683\u201399. https:\/\/doi.org\/10.3171\/2018.10.SPINE18802","journal-title":"J Neurosurg Spine"},{"key":"1172_CR31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/sc.2014.4","volume":"52","author":"E Widerstr\u00f6m-Noga","year":"2014","unstructured":"Widerstr\u00f6m-Noga E, Biering-S\u00f8rensen F, Bryce TN, Cardenas DD, Finnerup NB, Jensen MP, et al. The international spinal cord injury pain basic data set (version 2.0). Spinal Cord. 2014;52:282\u20136. 10.1038\/SC.2014.4;SUBJMETA","journal-title":"Spinal Cord"},{"key":"1172_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0304-3959(02)00452-9","volume":"103","author":"PJ Siddall","year":"2003","unstructured":"Siddall PJ, McClelland JM, Rutkowski SB, Cousins MJ. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain. 2003;103:249\u201357. https:\/\/doi.org\/10.1016\/S0304-3959(02)00452-9","journal-title":"Pain"},{"key":"1172_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ejp.522","volume":"19","author":"S Van Gorp","year":"2015","unstructured":"Van Gorp S, Kessels AG, Joosten EA, Van Kleef M, Patijn J. Pain prevalence and its determinants after spinal cord injury: A systematic review. European Journal of Pain. 2015;19:5\u201314. 10.1002\/EJP.522\/SUPPINFO","journal-title":"European Journal of Pain"},{"key":"1172_CR34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1213\/ANE.0B013E318249D36E","volume":"115","author":"H Clarke","year":"2012","unstructured":"Clarke H, Bonin RP, Orser BA, Englesakis M, Wijeysundera DN, Katz J. The prevention of chronic postsurgical pain using gabapentin and pregabalin: A combined systematic review and meta-analysis. Anesth Analg. 2012;115:428\u201342. https:\/\/doi.org\/10.1213\/ANE.0B013E318249D36E","journal-title":"Anesth Analg"},{"key":"1172_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/ALN.0000000000003428","volume":"133","author":"M Verret","year":"2020","unstructured":"Verret M, Lauzier F, Zarychanski R, Perron C, Savard X, Pinard AM, et al. Perioperative use of gabapentinoids for the management of postoperative acute pain: a systematic review and meta-analysis. Anesthesiology. 2020;133:265\u201379. https:\/\/doi.org\/10.1097\/ALN.0000000000003428","journal-title":"Anesthesiology"},{"key":"1172_CR36","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/S11096-022-01528-Y\/TABLES\/3","volume":"45","author":"J Meaadi","year":"2023","unstructured":"Meaadi J, Obara I, Eldabe S, Nazar H. The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials. Int. J. Clin. Pharm. 2023;45:556\u201365. https:\/\/doi.org\/10.1007\/S11096-022-01528-Y\/TABLES\/3","journal-title":"Int. J. Clin. Pharm."},{"key":"1172_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/00002508-200203000-00007","volume":"18","author":"JD Putzke","year":"2002","unstructured":"Putzke JD, Richards JS, Kezar L, Hicken BL, Ness TJ. Long-term use of gabapentin for treatment of pain after traumatic spinal cord injury. Clin J Pain. 2002;18:116\u201321. https:\/\/doi.org\/10.1097\/00002508-200203000-00007","journal-title":"Clin J Pain"},{"key":"1172_CR38","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/PHM.0B013E3182643C85","volume":"91","author":"FA Salinas","year":"2012","unstructured":"Salinas FA, Lugo LH, Garc\u00eda HI. Efficacy of early treatment with carbamazepine in prevention of neuropathic pain in patients with spinal cord injury. Am J Phys Med Rehabil. 2012;91:1020\u20137. https:\/\/doi.org\/10.1097\/PHM.0B013E3182643C85","journal-title":"Am J Phys Med Rehabil"},{"key":"1172_CR39","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.apmr.2021.09.018","volume":"103","author":"S Kirshblum","year":"2022","unstructured":"Kirshblum S, Botticello A, Benedetto J, Eren F, Donovan J, Marino R. Characterizing natural recovery of people with initial motor complete tetraplegia. Arch Phys Med Rehabil. 2022;103:649\u201356. https:\/\/doi.org\/10.1016\/j.apmr.2021.09.018","journal-title":"Arch Phys Med Rehabil"},{"key":"1172_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/J.APMR.2010.09.027","volume":"92","author":"RJ Marino","year":"2011","unstructured":"Marino RJ, Burns S, Graves DE, Leiby BE, Kirshblum S, Lammertse DP. Upper- and lower-extremity motor recovery after traumatic cervical spinal cord injury: an update from the national spinal cord injury database. Arch Phys Med Rehabil. 2011;92:369\u201375. https:\/\/doi.org\/10.1016\/J.APMR.2010.09.027","journal-title":"Arch Phys Med Rehabil"},{"key":"1172_CR41","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1089\/NEU.2008.0760","volume":"26","author":"MR Spiess","year":"2009","unstructured":"Spiess MR, M\u00fcller RM, Rupp R, Schuld C, Van Hedel HJA. Conversion in ASIA Impairment Scale during the First Year after Traumatic Spinal Cord Injury. J Neurotrauma. 2009;26:2027\u201336. https:\/\/doi.org\/10.1089\/NEU.2008.0760","journal-title":"J Neurotrauma"},{"key":"1172_CR42","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/NEUROS\/NYW053","volume":"80","author":"B Aarabi","year":"2017","unstructured":"Aarabi B, Sansur CA, Ibrahimi DM, Simard JM, Hersh DS, Le E, et al. Intramedullary lesion length on postoperative magnetic resonance imaging is a strong predictor of ASIA impairment scale grade conversion following decompressive surgery in cervical spinal cord injury. Clin Neurosurg. 2017;80:610\u201320. https:\/\/doi.org\/10.1093\/NEUROS\/NYW053","journal-title":"Clin Neurosurg"},{"key":"1172_CR43","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/S41393-019-0299-8","volume":"57","author":"AA Aimetti","year":"2019","unstructured":"Aimetti AA, Kirshblum S, Curt A, Mobley J, Grossman RG, Guest JD. Natural history of neurological improvement following complete (AIS A) thoracic spinal cord injury across three registries to guide acute clinical trial design and interpretation. Spinal Cord. 2019;57:753\u201362. https:\/\/doi.org\/10.1038\/S41393-019-0299-8","journal-title":"Spinal Cord"},{"key":"1172_CR44","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3171\/2017.7.SPINE17107","volume":"28","author":"NE El Tecle","year":"2018","unstructured":"El Tecle NE, Dahdaleh NS, Bydon M, Ray WZ, Torner JC, Hitchon PW. The natural history of complete spinal cord injury: a pooled analysis of 1162 patients and a meta-analysis of modern data. J Neurosurg Spine. 2018;28:436\u201343. https:\/\/doi.org\/10.3171\/2017.7.SPINE17107","journal-title":"J Neurosurg Spine"},{"key":"1172_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-024-71983-2","volume":"14","author":"V Stenimahitis","year":"2024","unstructured":"Stenimahitis V, Gharios M, Fletcher-Sandersj\u00f6\u00f6 A, El-Hajj VG, Singh A, Buwaider A, et al. Long-term outcome and predictors of neurological recovery in cervical spinal cord injury: a population-based cohort study. Sci Rep. 2024;14:20945 https:\/\/doi.org\/10.1038\/S41598-024-71983-2","journal-title":"Sci Rep"},{"key":"1172_CR46","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/PHM.0000000000001701","volume":"100","author":"P Mputu Mputu","year":"2021","unstructured":"Mputu Mputu P, Beaus\u00e9jour M, Richard-Denis A, Mac-Thiong JM. Early predictors of neurological outcomes after traumatic spinal cord injury: a systematic review and proposal of a conceptual framework. Am J Phys Med Rehabil. 2021;100:700\u201311. https:\/\/doi.org\/10.1097\/PHM.0000000000001701","journal-title":"Am J Phys Med Rehabil"},{"key":"1172_CR47","doi-asserted-by":"publisher","first-page":"e0323433","DOI":"10.1371\/JOURNAL.PONE.0323433","volume":"20","author":"D Yuan","year":"2025","unstructured":"Yuan D, Jin Y, Chen L, Tang M, Lin J, Chen W. Neurological outcomes and predictive factors in traumatic spinal cord injury patients in the intensive care unit. PLoS ONE. 2025;20:e0323433 https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0323433","journal-title":"PLoS ONE"},{"key":"1172_CR48","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41393-019-0286-0","volume":"57","author":"D Conradsson","year":"2019","unstructured":"Conradsson D, Phillips J, Nizeyimana E, Hilliar C, Joseph C. Risk indicators of length of acute hospital stay after traumatic spinal cord injury in South Africa: a prospective, population-based study. Spinal Cord. 2019;57:763\u20139. 10.1038\/S41393-019-0286-0;SUBJMETA","journal-title":"Spinal Cord"},{"key":"1172_CR49","doi-asserted-by":"publisher","first-page":"e681","DOI":"10.1016\/j.wneu.2022.07.072","volume":"166","author":"I Esmor\u00eds-Arij\u00f3n","year":"2022","unstructured":"Esmor\u00eds-Arij\u00f3n I, Galeiras R, Ferreiro Velasco ME, P\u00e9rtega D\u00edaz S. Predictors of intensive care unit stay in patients with acute traumatic spinal cord injury above T6. World Neurosurg. 2022;166:e681\u201391. https:\/\/doi.org\/10.1016\/j.wneu.2022.07.072","journal-title":"World Neurosurg."},{"key":"1172_CR50","doi-asserted-by":"publisher","first-page":"e70064","DOI":"10.1111\/JNC.70064","volume":"169","author":"Y Huang","year":"2025","unstructured":"Huang Y, Chen SR, Pan HL. \u03b12\u03b4-1-Linked NMDA and AMPA receptors in neuropathic pain and gabapentinoid action. J Neurochem. 2025;169:e70064 https:\/\/doi.org\/10.1111\/JNC.70064","journal-title":"J Neurochem"},{"key":"1172_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/JPET.120.266056","volume":"374","author":"CP Taylor","year":"2020","unstructured":"Taylor CP, Harris EW. Analgesia with gabapentin and pregabalin may involve N-methyl-D-aspartate receptors, neurexins, and thrombospondins. J. Pharmacology Exp. Therapeutics. 2020;374:161\u201374. https:\/\/doi.org\/10.1124\/JPET.120.266056","journal-title":"J. Pharmacology Exp. Therapeutics"},{"key":"1172_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","volume":"338","author":"M Kremer","year":"2016","unstructured":"Kremer M, Salvat E, Muller A, Yalcin I, Barrot M. Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights. Neuroscience. 2016;338:183\u2013206. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.06.057","journal-title":"Neuroscience"},{"key":"1172_CR53","doi-asserted-by":"publisher","first-page":"748","DOI":"10.4184\/ASJ.2015.9.5.748","volume":"9","author":"S Magu","year":"2015","unstructured":"Magu S, Singh D, Yadav RK, Bala M. Evaluation of traumatic spine by magnetic resonance imaging and correlation with neurological recovery. Asian Spine J. 2015;9:748\u201356. https:\/\/doi.org\/10.4184\/ASJ.2015.9.5.748","journal-title":"Asian Spine J"},{"key":"1172_CR54","doi-asserted-by":"publisher","first-page":"001","DOI":"10.1055\/S-0031-1296049","volume":"1","author":"JJ Middendorp","year":"2011","unstructured":"Middendorp JJ, van, Goss B, Urquhart S, Atresh S, Williams RP, et al. Diagnosis and prognosis of traumatic spinal cord injury. Glob Spine J. 2011;1:001\u20137. https:\/\/doi.org\/10.1055\/S-0031-1296049","journal-title":"Glob Spine J"},{"key":"1172_CR55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/RMHP.S168504","volume":"11","author":"AM Peckham","year":"2018","unstructured":"Peckham AM, Ananickal MJ, Sclar DA. Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance. Risk Manag Healthc Policy. 2018;11:109\u201316. https:\/\/doi.org\/10.2147\/RMHP.S168504","journal-title":"Risk Manag Healthc Policy"},{"key":"1172_CR56","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/ADD.13324","volume":"111","author":"RV Smith","year":"2016","unstructured":"Smith RV, Havens JR, Walsh SL. Gabapentin misuse, abuse and diversion: a systematic review. Addiction. 2016;111:1160\u201374. https:\/\/doi.org\/10.1111\/ADD.13324","journal-title":"Addiction"},{"key":"1172_CR57","doi-asserted-by":"publisher","first-page":"e1002396","DOI":"10.1371\/JOURNAL.PMED.1002396","volume":"14","author":"T Gomes","year":"2017","unstructured":"Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case\u2013control study. PLoS Med. 2017;14:e1002396 https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1002396","journal-title":"PLoS Med"},{"key":"1172_CR58","doi-asserted-by":"publisher","first-page":"e2031647","DOI":"10.1001\/jamanetworkopen.2020.31647","volume":"3","author":"K Bykov","year":"2020","unstructured":"Bykov K, Bateman BT, Franklin JM, Vine SM, Patorno E. Association of gabapentinoids with the risk of opioid-related adverse events in surgical patients in the United States. JAMA Netw. Open. 2020;3:e2031647 https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.31647","journal-title":"JAMA Netw. Open."},{"key":"1172_CR59","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1089\/NEU.2024.0375\/ASSET\/IMAGES\/NEU.2024.0375_FIGURE7.JPG","volume":"00","author":"J Rau","year":"2025","unstructured":"Rau J, Joseph R, Weise L, Bryan J, Wardeh J, Konda A, et al. Acute opioid administration undermines recovery after SCI: adverse effects are not restricted to morphine. J Neurotrauma. 2025;00:0\u2013000. https:\/\/doi.org\/10.1089\/NEU.2024.0375\/ASSET\/IMAGES\/NEU.2024.0375_FIGURE7.JPG","journal-title":"J Neurotrauma"},{"key":"1172_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.46292\/SCI2702-1","volume":"27","author":"R Rupp","year":"2021","unstructured":"Rupp R, Biering-S\u00f8rensen F, Burns SP, Graves DE, Guest J, Jones L, et al. International standards for neurological classification of spinal cord injury: revised 2019. Top Spinal Cord Inj Rehabil. 2021;27:1\u201322. https:\/\/doi.org\/10.46292\/SCI2702-1","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"1172_CR61","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/SJ.SC.3102044","volume":"45","author":"G Savic","year":"2007","unstructured":"Savic G, Bergstr\u00f6m EMK, Frankel HL, Jamous MA, Jones PW. Inter-rater reliability of motor and sensory examinations performed according to american spinal injury association standards. Spinal Cord. 2007;45:444\u201351. https:\/\/doi.org\/10.1038\/SJ.SC.3102044","journal-title":"Spinal Cord"},{"key":"1172_CR62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/S41393-021-00675-9","volume":"60","author":"E Lena","year":"2022","unstructured":"Lena E, Baroncini I, Pavese C, Musumeci G, Volini S, Masciullo M, et al. Reliability and validity of the international standards for neurological classification of spinal cord injury in patients with non-traumatic spinal cord lesions. Spinal Cord. 2022;60:30\u20136. https:\/\/doi.org\/10.1038\/S41393-021-00675-9","journal-title":"Spinal Cord"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41393-026-01172-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-026-01172-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-026-01172-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:03:32Z","timestamp":1773140612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41393-026-01172-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1172"],"URL":"https:\/\/doi.org\/10.1038\/s41393-026-01172-7","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Clinical Research Ethics Board at the University of British Columbia approved the study protocol (H21-03644).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}